GlassScriptPhysician profile
Ke H Tuan
NPI 1104873520
$1,170.29
in general payments reported to CMS, 2019-2025
11 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2021: $102 · 2022: $155 · 2023: $382 · 2024: $255 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.61 |
| Education | $109.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $378.04 | 2023-2024 | Veozah |
| Pfizer INC. | $207.44 | 2019-2023 | |
| Abbvie INC. | $141.54 | 2022-2025 | |
| Amgen INC. | $122.02 | 2022 | |
| Glaxosmithkline, LLC. | $100.00 | 2023 | Arexvy |
| Roche Diagnostics Corporation | $57.95 | 2019-2021 | |
| Minerva Surgical, INC | $42.53 | 2023-2024 | |
| Novo Nordisk INC | $38.55 | 2019 | |
| Exeltis, USA INC. | $33.26 | 2019-2021 | |
| Medicem INC. | $28.03 | 2023 | |
| Myovant Sciences INC. | $20.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ke H Tuan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.